Literature DB >> 24811178

Lipin 2 binds phosphatidic acid by the electrostatic hydrogen bond switch mechanism independent of phosphorylation.

James M Eaton1, Sankeerth Takkellapati1, Robert T Lawrence2, Kelley E McQueeney1, Salome Boroda1, Garrett R Mullins1, Samantha G Sherwood1, Brian N Finck3, Judit Villén2, Thurl E Harris4.   

Abstract

Lipin 2 is a phosphatidic acid phosphatase (PAP) responsible for the penultimate step of triglyceride synthesis and dephosphorylation of phosphatidic acid (PA) to generate diacylglycerol. The lipin family of PA phosphatases is composed of lipins 1-3, which are members of the conserved haloacid dehalogenase superfamily. Although genetic alteration of LPIN2 in humans is known to cause Majeed syndrome, little is known about the biochemical regulation of its PAP activity. Here, in an attempt to gain a better general understanding of the biochemical nature of lipin 2, we have performed kinetic and phosphorylation analyses. We provide evidence that lipin 2, like lipin 1, binds PA via the electrostatic hydrogen bond switch mechanism but has a lower rate of catalysis. Like lipin 1, lipin 2 is highly phosphorylated, and we identified 15 phosphosites. However, unlike lipin 1, the phosphorylation of lipin 2 is not induced by insulin signaling nor is it sensitive to inhibition of the mammalian target of rapamycin. Importantly, phosphorylation of lipin 2 does not negatively regulate either membrane binding or PAP activity. This suggests that lipin 2 functions as a constitutively active PA phosphatase in stark contrast to the high degree of phosphorylation-mediated regulation of lipin 1. This knowledge of lipin 2 regulation is important for a deeper understanding of how the lipin family functions with respect to lipid synthesis and, more generally, as an example of how the membrane environment around PA can influence its effector proteins.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Diacylglycerol; Enzyme Kinetics; Lipin 2; Phosphatidic Acid; Phosphatidic Acid Phosphatase; Phosphatidylethanolamine; Phosphorylation; Polybasic Domain; lpin2; mTOR

Mesh:

Substances:

Year:  2014        PMID: 24811178      PMCID: PMC4140300          DOI: 10.1074/jbc.M114.547604

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Molecular characterization of seipin and its mutants: implications for seipin in triacylglycerol synthesis.

Authors:  Weihua Fei; Hui Li; Guanghou Shui; Tamar S Kapterian; Christopher Bielby; Ximing Du; Andrew J Brown; Peng Li; Markus R Wenk; Pingsheng Liu; Hongyuan Yang
Journal:  J Lipid Res       Date:  2011-09-26       Impact factor: 5.922

2.  A protocol for rapid generation of recombinant adenoviruses using the AdEasy system.

Authors:  Jinyong Luo; Zhong-Liang Deng; Xiaoji Luo; Ni Tang; Wen-Xin Song; Jin Chen; Katie A Sharff; Hue H Luu; Rex C Haydon; Kenneth W Kinzler; Bert Vogelstein; Tong-Chuan He
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

3.  Protein structure prediction on the Web: a case study using the Phyre server.

Authors:  Lawrence A Kelley; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

4.  An electrostatic/hydrogen bond switch as the basis for the specific interaction of phosphatidic acid with proteins.

Authors:  Edgar E Kooijman; D Peter Tieleman; Christa Testerink; Teun Munnik; Dirk T S Rijkers; Koert N J Burger; Ben de Kruijff
Journal:  J Biol Chem       Date:  2007-02-03       Impact factor: 5.157

5.  Small-volume extrusion apparatus for preparation of large, unilamellar vesicles.

Authors:  R C MacDonald; R I MacDonald; B P Menco; K Takeshita; N K Subbarao; L R Hu
Journal:  Biochim Biophys Acta       Date:  1991-01-30

6.  The syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia. Report of a new family and a review.

Authors:  H A Majeed; M Al-Tarawna; H El-Shanti; B Kamel; F Al-Khalaileh
Journal:  Eur J Pediatr       Date:  2001-12       Impact factor: 3.183

7.  Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns.

Authors:  Jimmy Donkor; Meltem Sariahmetoglu; Jay Dewald; David N Brindley; Karen Reue
Journal:  J Biol Chem       Date:  2006-12-07       Impact factor: 5.157

8.  Seipin is a discrete homooligomer.

Authors:  Derk Binns; Sungkyung Lee; Christopher L Hilton; Qiu-Xing Jiang; Joel M Goodman
Journal:  Biochemistry       Date:  2010-11-18       Impact factor: 3.162

Review 9.  Lipins, lipinopathies, and the modulation of cellular lipid storage and signaling.

Authors:  Lauren S Csaki; Jennifer R Dwyer; Loren G Fong; Peter Tontonoz; Stephen G Young; Karen Reue
Journal:  Prog Lipid Res       Date:  2013-04-17       Impact factor: 16.195

10.  Analysis of naturally occurring mutations in the human lipodystrophy protein seipin reveals multiple potential pathogenic mechanisms.

Authors:  M F Michelle Sim; M Mesbah Uddin Talukder; Rowena J Dennis; Stephen O'Rahilly; J Michael Edwardson; Justin J Rochford
Journal:  Diabetologia       Date:  2013-08-30       Impact factor: 10.122

View more
  15 in total

1.  Liver-specific loss of lipin-1-mediated phosphatidic acid phosphatase activity does not mitigate intrahepatic TG accumulation in mice.

Authors:  George G Schweitzer; Zhouji Chen; Connie Gan; Kyle S McCommis; Nisreen Soufi; Roman Chrast; Mayurranjan S Mitra; Kui Yang; Richard W Gross; Brian N Finck
Journal:  J Lipid Res       Date:  2015-02-26       Impact factor: 5.922

Review 2.  Mammalian lipin phosphatidic acid phosphatases in lipid synthesis and beyond: metabolic and inflammatory disorders.

Authors:  Karen Reue; Huan Wang
Journal:  J Lipid Res       Date:  2019-02-25       Impact factor: 5.922

3.  Panoramic view of a superfamily of phosphatases through substrate profiling.

Authors:  Hua Huang; Chetanya Pandya; Chunliang Liu; Nawar F Al-Obaidi; Min Wang; Li Zheng; Sarah Toews Keating; Miyuki Aono; James D Love; Brandon Evans; Ronald D Seidel; Brandan S Hillerich; Scott J Garforth; Steven C Almo; Patrick S Mariano; Debra Dunaway-Mariano; Karen N Allen; Jeremiah D Farelli
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

4.  Multiscale Simulations of Biological Membranes: The Challenge To Understand Biological Phenomena in a Living Substance.

Authors:  Giray Enkavi; Matti Javanainen; Waldemar Kulig; Tomasz Róg; Ilpo Vattulainen
Journal:  Chem Rev       Date:  2019-03-12       Impact factor: 60.622

Review 5.  Chronic Recurrent Multifocal Osteomyelitis and Related Diseases-Update on Pathogenesis.

Authors:  Allison J Cox; Yongdong Zhao; Polly J Ferguson
Journal:  Curr Rheumatol Rep       Date:  2017-04       Impact factor: 4.592

Review 6.  How lipid droplets "TAG" along: Glycerolipid synthetic enzymes and lipid storage.

Authors:  Huan Wang; Michael V Airola; Karen Reue
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-06-20       Impact factor: 4.698

Review 7.  The ins and outs of endoplasmic reticulum-controlled lipid biosynthesis.

Authors:  Julie Jacquemyn; Ana Cascalho; Rose E Goodchild
Journal:  EMBO Rep       Date:  2017-10-26       Impact factor: 8.807

8.  The phosphatidic acid-binding, polybasic domain is responsible for the differences in the phosphoregulation of lipins 1 and 3.

Authors:  Salome Boroda; Sankeerth Takkellapati; Robert T Lawrence; Samuel W Entwisle; Jennifer M Pearson; Mitchell E Granade; Garrett R Mullins; James M Eaton; Judit Villén; Thurl E Harris
Journal:  J Biol Chem       Date:  2017-10-05       Impact factor: 5.157

Review 9.  Lipin proteins and glycerolipid metabolism: Roles at the ER membrane and beyond.

Authors:  Peixiang Zhang; Karen Reue
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-04-11       Impact factor: 4.019

10.  Lipid partitioning at the nuclear envelope controls membrane biogenesis.

Authors:  Antonio Daniel Barbosa; Hiroshi Sembongi; Wen-Min Su; Susana Abreu; Fulvio Reggiori; George M Carman; Symeon Siniossoglou
Journal:  Mol Biol Cell       Date:  2015-08-12       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.